BI 1060469

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 1060469, covering 2014-10-16 to 2015-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients [Phase 1]